Findings of the IMMUTACE Trial in Hepatocellular Carcinoma
Arndt Vogel, MD, discusses the study results of the IMMUTACE study in hepatocellular carcinoma.
Goals for TACE and Immunotherapy Trial in Intermediate-Stage HCC
Arndt Vogel, MD, discusses the goals of the IMMUTACE study investigating the efficacy of transarterial chemoembolization with nivolumab in patients with intermediate-stage hepatocellular carcinoma.